75 related articles for article (PubMed ID: 2735545)
1. Malignant hyperthermia-like syndrome associated with metrizamide myelography.
Ong RO; Rosenberg H
Anesth Analg; 1989 Jun; 68(6):795-7. PubMed ID: 2735545
[No Abstract] [Full Text] [Related]
2. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
[No Abstract] [Full Text] [Related]
3. Intrathecal dextrose to prevent seizures after metrizamide myelography in dogs.
Northington JW; Biery DN; Glickman LT
Invest Radiol; 1982; 17(3):282-3. PubMed ID: 6749752
[TBL] [Abstract][Full Text] [Related]
4. Metrizamide myelography risk factors: a pseudopsychiatric case presentation.
Blair R; Lippmann S
J Clin Psychiatry; 1985 Oct; 46(10):439-40. PubMed ID: 4044535
[TBL] [Abstract][Full Text] [Related]
5. Isoflurane and malignant hyperthermia.
Boheler J; Hamrick JC; McKnight RL; Eger EI
Anesth Analg; 1982 Aug; 61(8):712-3. PubMed ID: 7201277
[No Abstract] [Full Text] [Related]
6. Malignant hyperthermia induced by general anesthesia for bone marrow harvesting.
Hosoya N; Miyagawa K; Mimura T; Hoshide S; Akazawa H; Kanda Y; Takahashi N; Hirai H; Maekawa K; Yazaki Y
Bone Marrow Transplant; 1997 Mar; 19(5):509-11. PubMed ID: 9052921
[TBL] [Abstract][Full Text] [Related]
7. No response to trigger agents in a malignant hyperthermia-susceptible patient.
Claxton BA; Cross MH; Hopkins PM
Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia associated with isoflurane anesthesia.
Joseph MM; Shah K; Viljoen JF
Anesth Analg; 1982 Aug; 61(8):711-2. PubMed ID: 7201276
[No Abstract] [Full Text] [Related]
9. Use of pentobarbital sodium to reduce seizures in dogs after cervical myelography with metrizamide.
Gray PR; Indrieri RJ; Lowrie CT
J Am Vet Med Assoc; 1987 Jun; 190(11):1422-4. PubMed ID: 3610751
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous administration of dextrose or lactated Ringer's solution on seizure development in dogs after cervical myelography with metrizamide.
Gray PR; Lowrie CT; Wetmore LA
Am J Vet Res; 1987 Nov; 48(11):1600-2. PubMed ID: 3434904
[TBL] [Abstract][Full Text] [Related]
11. [Malignant hyperthermia].
Bouhajja B; Haddad F; Ben Ammar MS
Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
[TBL] [Abstract][Full Text] [Related]
12. Malignant hyperthermia in a liver transplant patient: a case report.
Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH
Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429
[TBL] [Abstract][Full Text] [Related]
13. [Acute meningitis following metrizamide myelography].
Sand T; Hesselberg JP; Dale LG; Anda S; Hellum K
Tidsskr Nor Laegeforen; 1985 Feb; 105(5):363-6. PubMed ID: 3983937
[No Abstract] [Full Text] [Related]
14. [A case of malignant hyperthermia induced by isoflurane].
Kenesi L; Gomard M; Rahmani J
Cah Anesthesiol; 1992; 40(6):430-2. PubMed ID: 1477762
[No Abstract] [Full Text] [Related]
15. Secretion of anti-diuretic hormone after metrizamide myelography.
Ruff SJ; Ryan MD
Med J Aust; 1983 Jun; 1(13):602-3. PubMed ID: 6855676
[No Abstract] [Full Text] [Related]
16. Metrizamide myelography.
Jelsma RK
Surg Neurol; 1982 Aug; 18(2):101. PubMed ID: 7135188
[No Abstract] [Full Text] [Related]
17. Multiple adverse reactions following metrizamide myelography.
Paschalis C; Sotiriadou C; Siablis D; Papapetropoulos T
J Neurol Neurosurg Psychiatry; 1985 Jul; 48(7):720-1. PubMed ID: 4031922
[No Abstract] [Full Text] [Related]
18. Malignant hyperthermia following isoflurane anesthesia in an American Lumbee Indian.
Meluch AM; Sibert KS; Bloch EC
N C Med J; 1989 Sep; 50(9):485-7. PubMed ID: 2601744
[No Abstract] [Full Text] [Related]
19. [Side effects of 2 water-soluble contrast media used in myelography].
Caillé JM
Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
[No Abstract] [Full Text] [Related]
20. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
Hogan KJ; Vladutiu GD
Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
